Literature DB >> 880977

A rotating iterative procedure (RIP) for estimating hybrid constants in multi-compartment analysis on desk computers.

H M von Hattingberg, D Brockmeier, G Kreuter.   

Abstract

The rotating iterative procedure (RIP) is a programming concept for non-linear least squares fitting of multiexponential equations to experimental data in pharmacokinetics. The method is economical in its use of program and active register capacity and can be employed in modern electronic desk-top computers. The algorithms necessary for obtaining primary estimates of various logarithmic components and their subsequent correction are presented, with as little higher mathematics as appeared permissible. The procedure is described in the sequence that would actually be followed in a pharmacokinetic analysis, and an example is included, as well as a skeleton version of a program written in BASIC. Some instructions for obtaining overall statistical parameters are given.

Mesh:

Substances:

Year:  1977        PMID: 880977     DOI: 10.1007/bf00566536

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN: 0031-6970            Impact factor:   2.953


  3 in total

1.  Statistical estimations in pharmacokinetics.

Authors:  H G Boxenbaum; S Riegelman; R M Elashoff
Journal:  J Pharmacokinet Biopharm       Date:  1974-04

2.  COMPT, a time-sharing program for nonlinear regression analysis of compartmental models of drug distribution.

Authors:  M Pfeffer
Journal:  J Pharmacokinet Biopharm       Date:  1973-04

3.  A new method for multi-compartment pharmacokinetic analysis: the Eigenvector Decomposition Principle.

Authors:  W Müller-Schauenburg
Journal:  Eur J Clin Pharmacol       Date:  1973-10       Impact factor: 2.953

  3 in total
  34 in total

1.  Pharmacokinetics and antibacterial activity of daily gentamicin.

Authors:  H Skopnik; R Wallraf; B Nies; K Tröster; G Heimann
Journal:  Arch Dis Child       Date:  1992-01       Impact factor: 3.791

2.  An extremely strange observation?

Authors:  Helmut Schütz
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2004 Jan-Mar       Impact factor: 2.441

3.  Pharmacokinetics of imipenem in patients undergoing major colon surgery.

Authors:  M Erttmann; R Krausse; U Ullmann
Journal:  Infection       Date:  1990 Nov-Dec       Impact factor: 3.553

4.  Flecainide: single and multiple oral dose kinetics, absolute bioavailability and effect of food and antacid in man.

Authors:  T B Tjandra-Maga; R Verbesselt; A Van Hecken; A Mullie; P J De Schepper
Journal:  Br J Clin Pharmacol       Date:  1986-09       Impact factor: 4.335

5.  [3H] UK-14,304, a new agonist ligand of alpha 2-adrenoceptors: a comparative study with human and rat tissue.

Authors:  H Rommelspacher; S Strauss; E Fähndrich; H J Haug
Journal:  J Neural Transm       Date:  1987       Impact factor: 3.575

6.  Influence of albumin on itraconazole and ketoconazole antifungal activity: results of a dynamic in vitro study.

Authors:  M Schäfer-Korting; H C Korting; F Amann; R Peuser; A Lukacs
Journal:  Antimicrob Agents Chemother       Date:  1991-10       Impact factor: 5.191

7.  Human plasma and skin blister fluid levels of griseofulvin following a single oral dose.

Authors:  M Schäfer-Korting; H C Korting; E Mutschler
Journal:  Eur J Clin Pharmacol       Date:  1985       Impact factor: 2.953

8.  Theophylline pharmacokinetics after intravenous infusion with ethylenediamine or sodium glycinate.

Authors:  J Caldwell; A H Staib; I A Cotgreave; M Siebert-Weigel
Journal:  Br J Clin Pharmacol       Date:  1986-09       Impact factor: 4.335

9.  Cefodizime penetration into skin suction blister fluid following a single intravenous dose.

Authors:  M Schäfer-Korting; H C Korting; L Maass; N Klesel; H G Grigoleit; E Mutschler
Journal:  Eur J Clin Pharmacol       Date:  1986       Impact factor: 2.953

10.  Influence of food intake on bioavailability of theophylline in premature infants.

Authors:  G Heimann; J Murgescu; U Bergt
Journal:  Eur J Clin Pharmacol       Date:  1982       Impact factor: 2.953

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.